comparemela.com

Page 13 - Ravi Anand News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Study results Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia.

Newron s evenamide brings good news for patients with CNS diseases

vimarsana © 2020. All Rights Reserved.